Aptar Pharma and MGH Advance Nose-to-Brain Drug Delivery
CRYSTAL LAKE, Ill. — September 14, 2026 Aptar Pharma and Massachusetts General Hospital (MGH) announced a research collaboration led...
depression
Advertisement
NRx Pharmaceuticals Deploys Robotic TMS Across HOPE Clinics
WILMINGTON, Del. — September 11, 2026 NRx Pharmaceuticals, Inc. announced that its subsidiary HOPE Therapeutics has begun training and...
Seaport Therapeutics Reports Positive Phase 1 GlyphAllo Data
BOSTON — September 9, 2026 Seaport Therapeutics, Inc. reported positive topline results from a Phase 1 driving simulation trial...
Definium Therapeutics to Present Phase 3 DT120 Data at Psych Congress
NEW YORK — September 10, 2026 Definium Therapeutics, Inc. announced plans to present six posters and an invited oral...
Seaport Therapeutics Advances GlyphAllo in Major Depression
BOSTON — September 9, 2026 Seaport Therapeutics, Inc. announced positive topline results from a Phase 1 driving simulation trial...
Advertisements
Lilly Acquires AtaiBeckley to Advance Depression Therapies
INDIANAPOLIS and NEW YORK, July 16, 2026 Eli Lilly and Company has announced a definitive agreement to acquire AtaiBeckley...
AtaiBeckley Completes Patient Dosing in Phase 2b VLS-01 TRD Trial
NEW YORK, July 6, 2026 AtaiBeckley Inc. announced that the final patient has been dosed in Elumina, its international...
AlzeCure, QuantumCell Partner to Advance NeuroRestore ACD856
STOCKHOLM, Sweden, July 1, 2026 AlzeCure Pharma AB has announced a landmark global out-licensing and collaboration agreement with Danish...
Nexalin Technology Highlights Positive Anxiety and Insomnia Data at NYC Neuromodulation Conference 2026
HOUSTON, Texas, June 16, 2026 Nexalin Technology announced that two clinical abstracts evaluating its proprietary Deep Intracranial Frequency Stimulation...
NRx Pharmaceuticals Highlights Real-World Ketamine Depression Data
MIAMI, June 5, 2026 NRx Pharmaceuticals, Inc. announced that new real-world evidence presented at the 2026 American Society of...
Advertisement
